Global Peptide Index
Get weekly changes

thymosin beta-4 fragment peptide

TB-500

US: Not on the registerEU: Not on the registerUK: Not on the registerCA: Not on the registerAU: Status unknownCH: Not on the registerBR: Not on the registerRS: Not on the registerSG: Not on the registerTR: Not on the register

Answer

TB-500 is not authorised on any of the 10 registers read, and 1 of them holds no reading for it. Highest trial phase: Phase 2. It has 1 registered trial, 1 of them running.

RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov, read 2026-10-03

Not medical, legal or regulatory advice.

Registered trials1Trial register ClinicalTrials.gov
Running now1Trial register recruiting, active or enrolling
Results posted0Trial register with results on the register
Stopped early0%Trial register all peptides: 10%

1 trials by status

Trial register
Running 1

ClinicalTrials.gov · read 2026-10-03 · 0 trials have posted results

Trials first submitted per year

Trial register

ClinicalTrials.gov first-submitted date, last 1 years · read 2026-10-03. 2026 is not complete.

Status by jurisdiction

World map
Authorised or registeredNot on the register, or withdrawnNot read yet, or status unknown
WhereStatusRegisterRead
United StatesNot on the registerFDA, openfda2026-10-03
European UnionNot on the registerEMA, ema2026-08-31
United KingdomNot on the registerMHRA, uk-mhra2026-09-03
CanadaNot on the registerHealth Canada, ca-dpd2026-09-03
AustraliaStatus unknownTGA, au-artgnot read
SwitzerlandNot on the registerSwissmedic, ch-swissmedic2026-09-03
BrazilNot on the registerANVISA, br-anvisa2026-09-03
SerbiaNot on the registerALIMS, rs-alims2026-09-03
SingaporeNot on the registerHSA, sg-hsa2026-09-03
TurkeyNot on the registerTITCK, tr-titck2026-09-03

An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.

CHANGE ALERTS

Get an email when this changes

One email when the status of TB-500 changes on the register. You confirm your address first.

ENFORCEMENT AND OFFICIAL ACTIONS

1 action by named authorities

Enforcement actions, board positions and payer rules that name TB-500, quoted from the source document. These are not approval decisions. This list shows the actions found so far. It is not a complete list: no authority publishes one.

US-OHenforcement
Ohio Board of Pharmacy, 2026-04-16
During the inspection, [redacted] was found to possess multiple vials of the following illegal dangerous drugs, in either a white powder, purple powder, or clear liquid form, intended for injection, which were obtained from an unlicensed, foreign source: g. BPC 157/TB500 10mg, 4 vials; k. TB500 10mg, 10 vials;
State of Ohio Board of Pharmacy, Order, Case No. A-2026-0037, Findings of Fact paragraphs 2(g) and 2(k) · quoted with the party redacted

REGISTERED TRIALS

1 trial, newest first

NCT07487363
TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD
currently recruiting participants · register updated 2026-03-23

All peptides · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.